Server:Apache...
The main IP address: 185.52.25.49,Your server United Kingdom,Buckingham ISP:Paragon Internet Group Limited TLD:uk CountryCode:GB
The description :pharma design limited offers advice and practical assistance to pharmaceutical and biotech companies from early development stage to market launch....
This report updates in 07-May-2019
Created Date: | 2010-07-22 |
Changed Date: | 2016-08-31 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host pharma-design.co.uk. Currently, hosted in United Kingdom and its service provider is Paragon Internet Group Limited .
Latitude: | 51.99967956543 |
Longitude: | -0.98778998851776 |
Country: | United Kingdom (GB) |
City: | Buckingham |
Region: | England |
ISP: | Paragon Internet Group Limited |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.
Transfer-Encoding: | chunked |
Set-Cookie: | wfvt_2208829913=5cd186cd676f1; expires=Tue, 07-May-2019 13:53:25 GMT; Max-Age=1800; path=/; HttpOnly |
Keep-Alive: | timeout=5, max=100 |
Server: | Apache |
Connection: | Keep-Alive |
Link: | |
Date: | Tue, 07 May 2019 13:23:24 GMT |
Content-Type: | text/html; charset=UTF-8 |
X-Pingback: | http://www.pharma-design.co.uk/xmlrpc.php |
soa: | ns1.tsohost.co.uk. serveremails.ebws.co.uk. 2016052805 10800 3600 604800 10800 |
ns: | ns1.tsohost.co.uk. ns2.tsohost.co.uk. |
ipv4: | IP:185.52.25.49 ASN:198047 OWNER:UKWEB-EQX, GB Country:GB |
mx: | MX preference = 5, mail exchanger = alt2.aspmx.l.google.com. MX preference = 1, mail exchanger = aspmx.l.google.com. MX preference = 10, mail exchanger = alt3.aspmx.l.google.com. MX preference = 5, mail exchanger = alt1.aspmx.l.google.com. MX preference = 10, mail exchanger = alt4.aspmx.l.google.com. |
[email protected] +44(0)20 3875 4111 - uk +353(0) 1902 0049 - ireland pharma design limited home pharma services market access regulatory consulting pharmacovigilance auditing and training product development capabilities news and updates articles about contact us careers market access, regulatory and clinical trial experts in europe pharma design is a small service provider with a network of specialised consultants. brexit ma licence transfers from uk to ireland and cta sponsorship change we assist pharmaceutical companies & biotechs in achieving marketing authorisations in europe and preparing adequately for market launch. we represent companies headquartered outside of the e.u. taking care of all their regulatory duties. finally we provide assistance with safety and quality of operations during development and post-marketing. strategic and regulatory advice marketing applications, scientific advice, paediatric advice orphan designation market access, hta and price analyses clinical trial design and cta submission clinical safety & pharmacovigilance establishment of european subsidiaries, headquarters, management teams pharma design is integrated into the ema and national regulatory authorities and is positioned to ensure that clients comply with all local laws and regulations. working with pharma design allows client companies to make an immediate strategic impact in europe and avoid the pitfalls and mistakes that are often made during a learning process. using our well-established outsourcing model ensures flexibility of approach from large-scale development projects, to discrete ‘modular’ technical reports or client-managed interim expertise on the ground, in europe. our services pharmacovigilance regulatory consulting product development auditing and training market access recent articles concept paper on the revision of ‘first-in-human’ guideline clinical trials ema has just released a concept paper to revise the first-in-human guideline and is requesting comments to address the need for updated and more streamlined… read more other recent articles the european medicines regulatory framework priority medicines (prime) top 5 issues to look out for in the access to medicines debate in europe see all articles news can you apply for a centralised marketing authorisation in europe ? medicinal products falling within the mandatory scope of the annex of regulation (ec) are obliged to apply for a centralised procedure: recombinant dna technology-controlled expression… read more other recent news justices debate lawsuits over generic drug safety should doctors shoulder healthcare costs? european medicines agency holds first stakeholder forum on the implementation of the new pharmacovigilance legislation see all news © 2019 pharma design limited powered by peadig
http://www.pharma-design.co.uk//tel:+353(0)
1902
0049
http://www.pharma-design.co.uk/pharmaceutical-news/european-medicines-agency-holds-first-stakeholder-forum-on-the-implementation-of-the-new-pharmacovigilance-legislation/
http://www.pharma-design.co.uk/articles/top-5-issues-look-access-medicines-debate-europe/
http://www.pharma-design.co.uk/articles/concept-paper-revision-first-human-guideline-clinical-trials/
http://www.pharma-design.co.uk/services/safety/
http://www.pharma-design.co.uk/pharmaceutical-news/
http://www.pharma-design.co.uk//tel:+44(0)20
3875
4111
http://www.pharma-design.co.uk/pharmaceutical-news/centralised-marketing-authorisation-europe/
http://www.pharma-design.co.uk/
http://www.pharma-design.co.uk/services/regulatory/
http://www.pharma-design.co.uk/articles/priority-medicines-prime/
http://www.pharma-design.co.uk/articles/european-medicines-regulatory-framework/
http://www.pharma-design.co.uk/pharmaceutical-news/should-doctors-shoulder-healthcare-costs/
http://www.pharma-design.co.uk/about/
http://www.pharma-design.co.uk/services/auditing-training/
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain name:
pharma-design.co.uk
Registrant:
simone cavani ruini
Registrant type:
UK Individual
Registrant's address:
PO Box 61359
Sunnyvale
CA
94088
United States
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 10-Dec-2012
Registrar:
Melbourne IT t/a Internet Names Worldwide [Tag = MELBOURNE-IT]
URL: http://www.melbourneit.com.au/contacts
Relevant dates:
Registered on: 22-Jul-2010
Expiry date: 22-Jul-2018
Last updated: 31-Aug-2016
Registration status:
Registered until expiry date.
Name servers:
ns1.firecask.com
ns2.firecask.com
WHOIS lookup made at 14:42:49 02-Nov-2017
--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REFERRER http://www.nominet.org.uk
REGISTRAR Nominet UK
SERVERS
SERVER co.uk.whois-servers.net
ARGS pharma-design.co.uk
PORT 43
TYPE domain
OWNER
ORGANIZATION simone cavani ruini
TYPE
UK Individual
ADDRESS
PO Box 61359
Sunnyvale
CA
94088
United States
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 10-Dec-2012
DOMAIN
SPONSOR Melbourne IT t/a Internet Names Worldwide [Tag = MELBOURNE-IT]
CREATED 2010-07-22
CHANGED 2016-08-31
STATUS
Registered until expiry date.
NSERVER
NS1.FIRECASK.COM 195.62.28.14
NS2.FIRECASK.COM 95.142.155.4
NAME pharma-design.co.uk
DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .